Singapore Clinical Trial: Beamion LUNG-3: A randomized, controlled, multi-center trial evaluating zongertinib as an adjuvant monotherapy compared with standard of care in patients with early-stage, resectable non-small cell lung cancer (Stage II-IIIB) harboring tyrosine kinase domain activating HER2 mutations

Singapore, Aug. 27 -- The Health Sciences Authority received information related to the study titled 'Beamion LUNG-3: A randomized, controlled, multi-center trial evaluating zongertinib as an adjuvant... Read More

Singapore Clinical Trial: A multicentre, randomised, double-blind, parallel group, placebo-controlled trial to assess the effects of oral TRPC6 inhibitor BI 764198 taken over a 104 week treatment period in adult and adolescent participants with primary focal segmental glomerulosclerosis (pFSGS) or genetic FSGS related to TRPC6 gene variants

Singapore, Aug. 27 -- The Health Sciences Authority received information related to the study titled 'A multicentre, randomised, double-blind, parallel group, placebo-controlled trial to assess the ef... Read More

Singapore Clinical Trial: A Phase 2b/Phase 3, randomized, double-blind, placebo-controlled, multicenter study, to investigate the efficacy and safety of lunsekimig in adult participants with inadequately controlled chronic obstructive pulmonary disease (COPD) characterized by an eosinophilic phenotype

Singapore, Aug. 27 -- The Health Sciences Authority received information related to the study titled 'A Phase 2b/Phase 3, randomized, double-blind, placebo-controlled, multicenter study, to investigat... Read More

Singapore Clinical Trial: A Phase 1, Randomized, Placebo-Controlled, Single Ascending Dose-Escalation Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY4167586 in Participants with Obesity or Overweight who are Otherwise Healthy.

Singapore, Aug. 27 -- The Health Sciences Authority received information related to the study titled 'A Phase 1, Randomized, Placebo-Controlled, Single Ascending Dose-Escalation Study to Investigate t... Read More

Singapore Clinical Trial: A Phase 3, Randomized, Open-label, Multicenter Clinical Study to Evaluate the Safety and Efficacy of MK-1084, Cetuximab, and mFOLFOX6 versus mFOLFOX6 With or Without Bevacizumab as First-line Treatment of Participants With KRAS G12C-mutant, Locally Advanced Unresectable or Metastatic Colorectal Cancer (KANDLELIT-012)

Singapore, Aug. 27 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Open-label, Multicenter Clinical Study to Evaluate the Safety and Efficacy ... Read More

बिहार विद्या साथी ऐप; अब घर बैठे 24 घंटे मिलेगी मुफ्त लाइव ट्यूशन और JEE-NEET परीक्षाओं की तैयारी

नई दिल्ली, अगस्त 27 -- बिहार के छात्रों के लिए JEE-NEET की पढ़ाई और बोर्ड परीक्षाओं की तैयारी को आसान बनाने की दिशा में एक बड़ी शुरुआत हुई है। मुख्यमंत्री सम्राट चौधरी ने पटना से वीडियो कॉन्फ्रेंसिंग ... Read More

JSW Group's Rs 40,000 Cr Odisha battery plant put on hold amid LFP technology challenge

Bhubaneswar, Aug. 27 -- The JSW Group put its proposed battery manufacturing plant in Odisha on hold as it continues its search for a technology partner for lithium iron phosphate (LFP) battery cells.... Read More

Which Country Produces the Most Cashew (Kaju) in the World? Check the Top Cashew-Producing Nation

India, Aug. 27 -- Cashews, popularly known as kaju in India, are among the most widely consumed tree nuts worldwide. People use them in sweets, snacks, desserts, and several traditional dishes. But ha... Read More

Karnataka facing unprecedented drought, Rs 635 crore allocated for relief: DCM G Parameshwara

Bengaluru, Aug. 27 -- Karnataka Deputy Chief Minister and Revenue Minister G Parameshwara on Thursday said the state is facing an unprecedented drought this year, with the state government earmarking ... Read More

Sensex falls 539 points, Nifty slips 0.48% as expiry volatility, Middle East uncertainty weigh

Mumbai, Aug. 27 -- Indian benchmark equity indices ended lower on Thursday, with the Sensex falling 539 points and Nifty declining 0.48 per cent, as expiry-led volatility and continued uncertainty ove... Read More

• ««
• «
• 123817
• 123818
• 123819
• 123820
• 123821
• 123822
• 123823
• 123824
• 123825
• 123826
• »
• »»